Our main priority is to ensure the availability of life-saving drugs for the citizens of Kazakhstan and Central Asia. SANTO plant has advanced technologies, high-tech equipment and qualified specialists producing drugs in accordance with international quality standards. This is our contribution to the care of public health and national security.Adam Aleksiejuk
SANTO CEO
1
billion
tablets
255
million
capsules
7,5
million
sachets
135
tons
of tablet mass by wet granulation
46.7
million
vials with cephalosporin antibiotics
15.5
million
vials with penem/mycin antibiotics
8.4
tons
of million vials with non-sterile liquid dosage forms.
250
million
injection ampoules
2.9
million
infusion bags and bottles
1882
Plant establishment
The SANTO plant is one of the oldest pharmaceutical
enterprises in Kazakhstan. It was founded in 1882 by
merchants Ivanov and Savenkov as a plant for the production
of the Santonin drug - an anthelmintic agent based on
wormwood (Artemisia cina). Today, a sprig of wormwood adorns
the coat of arms of Shymkent, for which the opening of a
pharmaceutical enterprise was a powerful impetus for
development.
1917-1991
Working in the USSR period
During the Soviet period, the plant was the largest producer
of pharmaceutical substances from raw plant materials and a
manufacturer of narcotic agents.
1993
Reorganization into Chimpharm JSC
Commencement of the pharmaceutical production large-scale
modernization in accordance with the international GMP
quality standard within the framework of the implementation
of an investment project worth about 108 million US dollars.
2011
Merger into Polpharma Group
Commencement of the pharmaceutical production large-scale
modernization in accordance with the international GMP
quality standard within the framework of the implementation
of an investment project worth about 108 million US dollars.
2014
Launching production of medicines in ampoules and
infusions
A new production workshop was opened within the framework of
the FIID State Program. At the moment, parenteral solutions
of large and small dosages are produced in this workshop.
2016
Launching production of antibiotic powders (GMP)
A new workshop for the production of antibiotic powders
(cephalosporins and penems/mycins) complies with the
international GMP standard. The production is arranged on
two separate lines.
2017
Launching production of oral solid dosage forms (GMP)
A new workshop for the production of oral solid dosage forms
by dry granulation method was launched as part of the
plant’s 135th anniversary celebration.
2018
Commencement of production of oral liquid dosage forms
(GMP) as well as modernization of the warehouse (GDP)
As part of the product range expansion, a new manufacturing
field was introduced - the production of oral liquid dosage
forms. GMP recertification was successfully passed, and a
GDP compliance certificate was obtained for the modernized
pharmacy warehouse of the plant.
2019
Commencement of production of oral solid dosage forms by wet
granulation method (GMP); the opening of the Digital
Engineering and Education Center as well as a sculpture
named “Looking into the Future” at the SANTO plant.
2020
Winning in the BEST RX CORPORATION OF KAZAKHSTAN 2020
nomination
For the first time, SANTO became a winner of IQVIA RX &
CONSUMER HEALTH AWARDS 2020 in the pharmaceutical market of
Kazakhstan in the BEST RX CORPORATION KAZAKHSTAN 2020
nomination.
2021
Winning the PARYZ Republican Contest
For the first time, SANTO became a winner of the Paryz-2021
Republican Contest on Social Responsibility in the
nomination “The Best Socially Responsible Enterprise”.
2021
Winning the EURASIAN PHARMA AWARD Contest
For the first time, SANTO became the winner of the Eurasian
Pharma Award-2021 Contest in the nomination “Local Company
of the Year”.
